Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Opko Health Inc's Business Segments
Opko Health Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 164
Regions Reported
1
Opko Health Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Region - Q2 FY2026
- Other Countries0.7%
Revenue by Geographic Region - Q2 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Other Countries | $ 1 | 0.7% |
Revenue by Product & Service Category - Q2 FY2026
- Service45.6%
- Intellectual Property and Other28.2%
- Transfer of Intellectual Property and Other28.2%
- Product26.3%
- Rayaldee8.7%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Service | $ 75 | 45.6% |
| Intellectual Property and Other | $ 46 | 28.2% |
| Transfer of Intellectual Property and Other | $ 46 | 28.2% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
2 more categories available
Sign in to unlock the full Opko Health Inc dataset.
Description of Opko Health Inc
Opko Health Inc is a multi-billion dollar healthcare provider that specializes in diagnostic and pharmaceutical products, especially those related to genetic testing, diagnostics and medical devices along with pharmaceuticals. Founded by Dr. Phillip Frost in 1991, the company is headquartered in Miami, Florida and has a global presence across North America, Europe, Asia and South America. The company has a diverse portfolio of products and services with emphasis on precision medicine and personalized healthcare.
Opko Health has three main divisions – pharmaceuticals, diagnostics and laboratory services. They provide genomic testing and analysis to detect and treat various diseases such as cancer, hepatitis, cardiovascular diseases, endocrinology and infectious diseases. The company's diagnostics division produces a wide range of products, including genetic and infectious disease tests and imaging services. They have also developed a Point-of-Care (POC) testing device for COVID-19, which can be used at clinics, hospitals and testing centers.
The company's pharmaceutical division develops and commercializes products for various diseases such as chronic kidney disease, growth hormone deficiency, vitamin D deficiency and prostate cancer. OPKO Biologics is the subsidiary of the company which produces a range of products based on innovative technology such as RNA interference (RNAi) and gene therapy.
Opko Health also provides laboratory services to medical providers, hospitals and clinics across the world with their subsidiary BioReference Laboratories. The laboratory services include molecular diagnostics, genomic testing and pathology services. It has been recognized for quality and performance with clinical excellence awards from various medical organizations.
Opko Health has a strong pipeline of products with a focus on precision medicine and personalized healthcare. It has both in-house R&D and collaborations with other pharmaceutical companies to develop new treatment and diagnostic products that meet patient needs. The company has also received several approvals from the US Food and Drug Administration (FDA) for its products and devices.
In conclusion, Opko Health Inc is a major healthcare provider with an extensive range of products and services, and a strong focus on innovation, precision medicine and personalized healthcare. It has a global presence and is dedicated to improving patient outcomes and creating value for shareholders.
Opko Health has three main divisions – pharmaceuticals, diagnostics and laboratory services. They provide genomic testing and analysis to detect and treat various diseases such as cancer, hepatitis, cardiovascular diseases, endocrinology and infectious diseases. The company's diagnostics division produces a wide range of products, including genetic and infectious disease tests and imaging services. They have also developed a Point-of-Care (POC) testing device for COVID-19, which can be used at clinics, hospitals and testing centers.
The company's pharmaceutical division develops and commercializes products for various diseases such as chronic kidney disease, growth hormone deficiency, vitamin D deficiency and prostate cancer. OPKO Biologics is the subsidiary of the company which produces a range of products based on innovative technology such as RNA interference (RNAi) and gene therapy.
Opko Health also provides laboratory services to medical providers, hospitals and clinics across the world with their subsidiary BioReference Laboratories. The laboratory services include molecular diagnostics, genomic testing and pathology services. It has been recognized for quality and performance with clinical excellence awards from various medical organizations.
Opko Health has a strong pipeline of products with a focus on precision medicine and personalized healthcare. It has both in-house R&D and collaborations with other pharmaceutical companies to develop new treatment and diagnostic products that meet patient needs. The company has also received several approvals from the US Food and Drug Administration (FDA) for its products and devices.
In conclusion, Opko Health Inc is a major healthcare provider with an extensive range of products and services, and a strong focus on innovation, precision medicine and personalized healthcare. It has a global presence and is dedicated to improving patient outcomes and creating value for shareholders.
Opko Health Inc. is a prominent multinational healthcare company specializing in the research, development, and commercialization of a diverse array of innovative pharmaceuticals and diagnostic products designed to enhance patient health outcomes. The company is structured into several key segments, each catering to specific patient groups and healthcare needs, thus providing a comprehensive suite of products and services.
1. Pharma Segment
The pharmaceutical segment of Opko Health encompasses a wide array of therapeutic products and cutting-edge drug delivery technologies aimed at treating complex medical conditions. Here are some of the major offerings within this segment:
- Rayaldee: This is an innovative vitamin D-based prohormone that plays a critical role in regulating calcium levels in patients suffering from chronic kidney disease (CKD) and secondary hyperparathyroidism. Its mechanism helps manage the balance of calcium and phosphorus, which is crucial for patients in chronic renal insufficiency.
- Opko Biologics: This subsidiary focuses on the development of biosimilar and innovative biological therapies. Its portfolio includes treatments for patients with a variety of autoimmune diseases as well as cancer, positioning Opko Biologics as a significant player in the biopharmaceutical space. The aim is to provide effective therapeutic alternatives that improve quality of life.
- HCT/Ps (Human Cells, Tissues, and Cellular and Tissue-Based Products): These products are utilized in cellular therapies for the treatment of various medical conditions. This includes regenerative medicine approaches that capitalize on the therapeutic potential of human cells and tissues.
Diagnostic Segment
Opko Healths diagnostics segment is rich in products and services that facilitate timely and accurate disease diagnosis. This segment includes:
- 4Kscore Test: A groundbreaking blood test that delivers a personalized risk score related to the likelihood of aggressive prostate cancer. The test helps clinicians make informed decisions regarding the necessity of biopsies, thereby guiding treatment pathways effectively.
- Claros: This point-of-care diagnostic platform allows healthcare providers to obtain lab-quality results swiftly, often within minutes. The system enhances the ability to diagnose conditions and initiate treatment without the delays traditionally associated with sending samples to external laboratories.
- GeneDx: A market leader in genetic diagnostics, GeneDx specializes in offering comprehensive testing services for various inherited and complex genetic disorders. Their advanced sequencing technologies provide insights that are pivotal in managing these conditions across different patient demographics.
Laboratory Services Segment
Opko Health extends its reach in healthcare through an extensive laboratory services segment. This segment includes the following:
- BioReference Laboratories: One of the leading providers of clinical laboratory testing services in the United States, BioReference offers an extensive suite of over 4,000 tests catering to various diagnostic needs. It serves patients, physicians, and large healthcare organizations, ensuring accessibility to critical laboratory services.
- GenPath Womens Health: This specialized laboratory focuses on womens health, offering testing services that address reproductive health, oncology, and genetics. Its tailored approach helps women navigate health issues throughout their lifespan, emphasizing the importance of specialized care in this demographic.
- Spectra Labs: This laboratory is dedicated to the testing of medical cannabis and hemp products. It ensures the quality, safety, and efficacy of these products, which is crucial given the growing acceptance and use of cannabis in various therapeutic contexts.
Conclusion
In summary, Opko Health Inc. possesses a robust and diversified portfolio of products and services segmented into pharmaceuticals, diagnostics, and laboratory services. Each segment is driven by continuous innovation and a commitment to improving patient health outcomes across the globe. The companys strategic focus on research and development empowers it to stay ahead in the competitive healthcare landscape, ultimately benefiting patients with complex health needs. Through its multifaceted approach, Opko Health is dedicated to advancing healthcare solutions that enhance the well-being of individuals and communities.
1. Pharma Segment
The pharmaceutical segment of Opko Health encompasses a wide array of therapeutic products and cutting-edge drug delivery technologies aimed at treating complex medical conditions. Here are some of the major offerings within this segment:
- Rayaldee: This is an innovative vitamin D-based prohormone that plays a critical role in regulating calcium levels in patients suffering from chronic kidney disease (CKD) and secondary hyperparathyroidism. Its mechanism helps manage the balance of calcium and phosphorus, which is crucial for patients in chronic renal insufficiency.
- Opko Biologics: This subsidiary focuses on the development of biosimilar and innovative biological therapies. Its portfolio includes treatments for patients with a variety of autoimmune diseases as well as cancer, positioning Opko Biologics as a significant player in the biopharmaceutical space. The aim is to provide effective therapeutic alternatives that improve quality of life.
- HCT/Ps (Human Cells, Tissues, and Cellular and Tissue-Based Products): These products are utilized in cellular therapies for the treatment of various medical conditions. This includes regenerative medicine approaches that capitalize on the therapeutic potential of human cells and tissues.
Diagnostic Segment
Opko Healths diagnostics segment is rich in products and services that facilitate timely and accurate disease diagnosis. This segment includes:
- 4Kscore Test: A groundbreaking blood test that delivers a personalized risk score related to the likelihood of aggressive prostate cancer. The test helps clinicians make informed decisions regarding the necessity of biopsies, thereby guiding treatment pathways effectively.
- Claros: This point-of-care diagnostic platform allows healthcare providers to obtain lab-quality results swiftly, often within minutes. The system enhances the ability to diagnose conditions and initiate treatment without the delays traditionally associated with sending samples to external laboratories.
- GeneDx: A market leader in genetic diagnostics, GeneDx specializes in offering comprehensive testing services for various inherited and complex genetic disorders. Their advanced sequencing technologies provide insights that are pivotal in managing these conditions across different patient demographics.
Laboratory Services Segment
Opko Health extends its reach in healthcare through an extensive laboratory services segment. This segment includes the following:
- BioReference Laboratories: One of the leading providers of clinical laboratory testing services in the United States, BioReference offers an extensive suite of over 4,000 tests catering to various diagnostic needs. It serves patients, physicians, and large healthcare organizations, ensuring accessibility to critical laboratory services.
- GenPath Womens Health: This specialized laboratory focuses on womens health, offering testing services that address reproductive health, oncology, and genetics. Its tailored approach helps women navigate health issues throughout their lifespan, emphasizing the importance of specialized care in this demographic.
- Spectra Labs: This laboratory is dedicated to the testing of medical cannabis and hemp products. It ensures the quality, safety, and efficacy of these products, which is crucial given the growing acceptance and use of cannabis in various therapeutic contexts.
Conclusion
In summary, Opko Health Inc. possesses a robust and diversified portfolio of products and services segmented into pharmaceuticals, diagnostics, and laboratory services. Each segment is driven by continuous innovation and a commitment to improving patient health outcomes across the globe. The companys strategic focus on research and development empowers it to stay ahead in the competitive healthcare landscape, ultimately benefiting patients with complex health needs. Through its multifaceted approach, Opko Health is dedicated to advancing healthcare solutions that enhance the well-being of individuals and communities.